India to Australia: Docusate Export Trade Route

The India to Australia Docusate corridor is one of India's established pharmaceutical export routes, with 81 shipments documented worth a combined $1.2M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's docusate manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $14.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with docusate's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 24.9%, placing it at rank #3 among India's top docusate export destinations globally.

On the import side, key buyers of Indian docusate in Australia include APOTEX AUSTRALIA, GENERIC HEALTH, NOUMED PHARMACEUTICALS PTY LIMITED and 11 others. APOTEX AUSTRALIA is the single largest importer with 33 shipments valued at $302.6K USD.

India's docusate exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 62 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, SUNGLOW LIFESCIENCE PRIVATE LIMITED, SUNGLOW LIFESCIENCE PRIVATE LIMITED — together account for 92% of total trade value on this route. The average shipment value of $14.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pa colox-senna 200 tablet bottle.(docusate sodium and sennosides tablets 50 mg8mg tablets)51232set2.35 and pa colox-senna 200 tablet bottle(docusate sodium 50mg and sennasides 8mg tablets)set, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, APOTEX AUSTRALIA is the largest importer with 33 shipments worth $302.6K USD — representing 25% of all docusate imports from India on this route. A total of 14 buyers are active on this corridor.